#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glioblastoma multiforme Round cell liposarcoma Squamous cell carcinoma of head and neck Anti-myelin-associated glycoprotein antibodies positive Follicular lymphoma stage II Chronic hepatitis B Piriformis syndrome Blood iron increased Pelizaeus-Merzbacher disease Philadelphia positive chronic myeloid leukaemia Primary amyloidosis Ventricular fibrillation Congenital disorder of glycosylation Liver transplant rejection Glomerulonephritis membranous More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Basic Information Basal cell naevus syndrome – Diagnostics Breast angiosarcoma – Diagnostics Lymphangiosarcoma – Trials in Disease Ocular melanoma – Life with Disease CADASIL Factor IX deficiency – Diagnostics Stevens-Johnson syndrome – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Hereditary motor and sensory neuropathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nipocalimab Immunglobulin Iloprost Trometamol Tilmanocept Upadacitinib Onfekafusp Alfa Omp66 Barzolvolimab Cerebrolysin Concentrate Bictegravir Azd8630 Xanomeline Tartrate Haloperidol GSKVX000000034794 20-HYDROXYECDYSONE Mebeverine Hydrochloride Felis Domesticus (555) Pamapimod Rintatolimod Indacaterol Maleate More therapies…

    Learn about Your Condition

    Malignant melanoma stage II HER2 positive gastric cancer Radicular pain Arrhythmia Post-traumatic stress disorder Ventricular extrasystoles Hypochondroplasia Perineal injury Idiopathic pulmonary fibrosis Cardiac arrest Ovarian cancer Hypoparathyroidism B-cell type acute leukaemia T-cell type acute leukaemia Barrett's oesophagus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    France

  • Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    • Venetoclax
    Austria Belgium Denmark Estonia Finland France +8

  • Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Croatia Czechia Denmark France +10

  • Study on Inhaled Molgramostim for Children with Autoimmune Pulmonary Alveolar Proteinosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Molgramostim
    Germany

  • Study on the Effects of EH-301, N-Acetylcysteine, and Riluzole in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    1 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Acetylcysteine
    • Riluzole
    Spain

  • Study on the Safety and Effects of Lutetium Lu-177 and ABY-271 in Patients with HER2-Positive Metastatic Breast Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • ABY-271
    • LUTETIUM LU-177
    Belgium Germany Norway Sweden
Previous Page
1 … 227 228 229 230 231 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!